Skip to content
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis
Cover Image

Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese, Mario Tiribelli, Erika Morsia, Mirko Farina, Giulia Benevolo, Eloise Beggiato, Bruno Martino, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Alessandra Iurlo, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Andrea Duminuco, Daniele Cattaneo, Roberto M. Lemoli, Costanza Bosi, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Chiara Sartor, Florian H. Heidel, Massimo Breccia, Filippo Branzanti, Giuseppe A. Palumbo, Massimiliano Bonifacio, Elena M. Elli
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
Cancer
Online Access:
Acceder al recurso
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70320

Similar Items

  • Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib
    by: PALANDRI, FRANCESCA, et al.
    Published: (2024)
  • Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)
    by: Massimo Breccia, et al.
    Published: (2025)
  • Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point?
    by: Andrea Duminuco, et al.
    Published: (2024)
  • Chronic eosinophilic leukaemia—Not otherwise specified: Clinical features, genomic insight and therapeutic strategies
    by: Alessandro Costa, et al.
    Published: (2024)
  • Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
    by: Alessandro Laganà, et al.
    Published: (2024)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar